Toxicity-reducing potential of extracorporeal affinity adsorption treatment in combination with the auristatin-conjugated monoclonal antibody BR96 in a syngeneic rat tumor model.

Autor: Nilsson R, Mårtensson L, Eriksson SE, Sjögren HO, Tennvall J
Zdroj: Cancer (0008543X); 2/15/2010 Supplement, Vol. 116, p1033-1042, 10p
Databáze: Complementary Index
Externí odkaz: